
LINK . SPRINGER . COM {
}
Title:
Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment | Journal of Cancer Research and Clinical Oncology
Description:
This study was attempted to investigate the safety and clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell therapy for treating stage III/IV pancreatic cancer, evaluate median progression-free survival (PFS), and overall survival (OS). Between March 2016 and February 2017, we enrolled 67 patients who met the enrollment criteria. According to the latest NCCN Guidelines, the patients were divided into stage III (35 patients, 16 patients received only irreversible electroporation (IRE) and 19 patients received IRE-NK: 8 patients underwent one course NK and 11 patients underwent â„3 courses) and stage IV (32 patients, 14 patients received only IRE and 18 patients received IRE-NK: 8 patients underwent one course NK and 10 patients underwent â„3 courses). The safety and short-term effects were evaluated first, then the median PFS, median OS, response rate (RR) and disease control rate (DCR) were assessed. Adverse events of all patients were limited to grades A and B, included local (mainly cough 12.7%, nausea and emesis 6.8%, pain of puncture point 25.3% and duodenum and gastric retention 5.9%) and systemic (mainly fatigue 21.5, fever 33.5%, and blood pressure intraoperative transient reduction 27.4% and white cell count reduction 22.6%) reactions, fever was most frequent. The serum amylase level at 24 h and 7 d after IRE was not significantly changed compared to those before IRE (P > 0.05). CA19-9 value was lower in IRE-NK group than in IRE at 1 month after treatment (P < 0.05). After a median follow-up of 7.9 months (3.8â12.1 months): in stage III group, median PFS was higher in IRE-NK group (9.1 months) than in IRE group (7.9 months, P = 0.0432), median OS was higher in IRE-NK (13.6 months) than in IRE (12.2 months; P = 0.0327), and median PFS was higher in who received multiple NK than single NK (9.9 vs. 8.2 months; P = 0.0387, respectively), median OS who received multiple NK was higher than single NK (13.7 vs. 12.1 months; P = 0.0451, respectively), the RR in IRE-NK (63.2%) was higher than in IRE (50.0%; P < 0.05); in stage IV group, median OS was higher in IRE-NK (10.2 months) than in IRE (9.1 months; P = 0.0367), the DCR in IRE-NK (66.7%) was higher than in IRE (42.9%; P < 0.05). Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy significantly increased median PFS and median OS in stage III pancreatic cancer and extended the median OS of stage IV pancreatic cancer. Multiple allogeneic natural killer cells infusion was associated with better prognosis to stage III pancreatic cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {đ}
- Health & Fitness
- Education
- Science
Content Management System {đ}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {đ}
What is the average monthly size of link.springer.com audience?
đ Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {đž}
We find it hard to spot revenue streams.
Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com has a secret sauce for making money, but we can't detect it yet.
Keywords {đ}
pubmed, cancer, article, google, scholar, cas, patients, pancreatic, cell, killer, irreversible, electroporation, cells, treatment, advanced, immunotherapy, lung, central, stage, median, natural, ire, months, locally, zhang, immunol, dois, oncol, surg, clinical, percutaneous, chen, niu, efficacy, irenk, cytokineinduced, liang, wang, safety, received, higher, combination, research, oncology, combined, allogeneic, study, survival, pfs, iii,
Topics {âïž}
cytokine-induced killer cells month download article/chapter small-cell lung cancer small-cell lung cancer cd158a + human nk cells kir/hla ligand incompatibility autologous dendritic cells nk cell-based immunotherapy her2-expressing breast cancer related subjects image-guided tumor ablation stage iii/iv postoperative adjuvant therapy killer cell immunoglobulin full article pdf fuda cancer hospital percutaneous irreversible electroporation unresectable pancreatic adenocarcinoma enhanced antitumor effects clinical oncology aims t4 pancreatic cancer metastatic pancreatic cancer significantly changed compared percutaneous cryoablation combined bone marrow transplantation pancreatic adenocarcinoma patients stage iv group advanced renal cancer privacy choices/manage cookies pancreatic cancer treatment stage iii group lizhi niu circulating tumor cells dendritic cells combining article lin metastatic hepatocellular cancer anti-pd-1 antibody received multiple nk adjuvant therapy check access instant access short-term effects tumor-specific cytotoxic hla-cw4 expression metastatic nasopharyngeal carcinoma ethics declarations conflict disease control rate pancreatic cancer european economic area serum amylase level
Schema {đșïž}
WebPage:
mainEntity:
headline:Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment
description:This study was attempted to investigate the safety and clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell therapy for treating stage III/IV pancreatic cancer, evaluate median progression-free survival (PFS), and overall survival (OS). Between March 2016 and February 2017, we enrolled 67 patients who met the enrollment criteria. According to the latest NCCN Guidelines, the patients were divided into stage III (35 patients, 16 patients received only irreversible electroporation (IRE) and 19 patients received IRE-NK: 8 patients underwent one course NK and 11 patients underwent â„3 courses) and stage IV (32 patients, 14 patients received only IRE and 18 patients received IRE-NK: 8 patients underwent one course NK and 10 patients underwent â„3 courses). The safety and short-term effects were evaluated first, then the median PFS, median OS, response rate (RR) and disease control rate (DCR) were assessed. Adverse events of all patients were limited to grades A and B, included local (mainly cough 12.7%, nausea and emesis 6.8%, pain of puncture point 25.3% and duodenum and gastric retention 5.9%) and systemic (mainly fatigue 21.5, fever 33.5%, and blood pressure intraoperative transient reduction 27.4% and white cell count reduction 22.6%) reactions, fever was most frequent. The serum amylase level at 24 h and 7 d after IRE was not significantly changed compared to those before IRE (P > 0.05). CA19-9 value was lower in IRE-NK group than in IRE at 1 month after treatment (P < 0.05). After a median follow-up of 7.9 months (3.8â12.1 months): in stage III group, median PFS was higher in IRE-NK group (9.1 months) than in IRE group (7.9 months, P = 0.0432), median OS was higher in IRE-NK (13.6 months) than in IRE (12.2 months; P = 0.0327), and median PFS was higher in who received multiple NK than single NK (9.9 vs. 8.2 months; P = 0.0387, respectively), median OS who received multiple NK was higher than single NK (13.7 vs. 12.1 months; P = 0.0451, respectively), the RR in IRE-NK (63.2%) was higher than in IRE (50.0%; P < 0.05); in stage IV group, median OS was higher in IRE-NK (10.2 months) than in IRE (9.1 months; P = 0.0367), the DCR in IRE-NK (66.7%) was higher than in IRE (42.9%; P < 0.05). Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy significantly increased median PFS and median OS in stage III pancreatic cancer and extended the median OS of stage IV pancreatic cancer. Multiple allogeneic natural killer cells infusion was associated with better prognosis to stage III pancreatic cancer.
datePublished:2017-09-04T00:00:00Z
dateModified:2017-09-04T00:00:00Z
pageStart:2607
pageEnd:2618
sameAs:https://doi.org/10.1007/s00432-017-2513-4
keywords:
Percutaneous irreversible electroporation
Allogeneic natural killer cell
Pancreatic cancer
Clinical efficacy
Oncology
Cancer Research
Internal Medicine
Hematology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig6_HTML.gif
isPartOf:
name:Journal of Cancer Research and Clinical Oncology
issn:
1432-1335
0171-5216
volumeNumber:143
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Mao Lin
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Shuzhen Liang
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Xiaohua Wang
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yinqing Liang
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Mingjie Zhang
affiliation:
name:Hank Bioengineering Co., Ltd
address:
name:Hank Bioengineering Co., Ltd, Shenzhen, China
type:PostalAddress
type:Organization
type:Person
name:Jibing Chen
url:http://orcid.org/0000-0001-8596-2126
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Lizhi Niu
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
name:Jinan University School
address:
name:Department of Oncology, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Kecheng Xu
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment
description:This study was attempted to investigate the safety and clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell therapy for treating stage III/IV pancreatic cancer, evaluate median progression-free survival (PFS), and overall survival (OS). Between March 2016 and February 2017, we enrolled 67 patients who met the enrollment criteria. According to the latest NCCN Guidelines, the patients were divided into stage III (35 patients, 16 patients received only irreversible electroporation (IRE) and 19 patients received IRE-NK: 8 patients underwent one course NK and 11 patients underwent â„3 courses) and stage IV (32 patients, 14 patients received only IRE and 18 patients received IRE-NK: 8 patients underwent one course NK and 10 patients underwent â„3 courses). The safety and short-term effects were evaluated first, then the median PFS, median OS, response rate (RR) and disease control rate (DCR) were assessed. Adverse events of all patients were limited to grades A and B, included local (mainly cough 12.7%, nausea and emesis 6.8%, pain of puncture point 25.3% and duodenum and gastric retention 5.9%) and systemic (mainly fatigue 21.5, fever 33.5%, and blood pressure intraoperative transient reduction 27.4% and white cell count reduction 22.6%) reactions, fever was most frequent. The serum amylase level at 24 h and 7 d after IRE was not significantly changed compared to those before IRE (P > 0.05). CA19-9 value was lower in IRE-NK group than in IRE at 1 month after treatment (P < 0.05). After a median follow-up of 7.9 months (3.8â12.1 months): in stage III group, median PFS was higher in IRE-NK group (9.1 months) than in IRE group (7.9 months, P = 0.0432), median OS was higher in IRE-NK (13.6 months) than in IRE (12.2 months; P = 0.0327), and median PFS was higher in who received multiple NK than single NK (9.9 vs. 8.2 months; P = 0.0387, respectively), median OS who received multiple NK was higher than single NK (13.7 vs. 12.1 months; P = 0.0451, respectively), the RR in IRE-NK (63.2%) was higher than in IRE (50.0%; P < 0.05); in stage IV group, median OS was higher in IRE-NK (10.2 months) than in IRE (9.1 months; P = 0.0367), the DCR in IRE-NK (66.7%) was higher than in IRE (42.9%; P < 0.05). Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy significantly increased median PFS and median OS in stage III pancreatic cancer and extended the median OS of stage IV pancreatic cancer. Multiple allogeneic natural killer cells infusion was associated with better prognosis to stage III pancreatic cancer.
datePublished:2017-09-04T00:00:00Z
dateModified:2017-09-04T00:00:00Z
pageStart:2607
pageEnd:2618
sameAs:https://doi.org/10.1007/s00432-017-2513-4
keywords:
Percutaneous irreversible electroporation
Allogeneic natural killer cell
Pancreatic cancer
Clinical efficacy
Oncology
Cancer Research
Internal Medicine
Hematology
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig1_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig2_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig3_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig4_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig5_HTML.gif
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00432-017-2513-4/MediaObjects/432_2017_2513_Fig6_HTML.gif
isPartOf:
name:Journal of Cancer Research and Clinical Oncology
issn:
1432-1335
0171-5216
volumeNumber:143
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Mao Lin
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Shuzhen Liang
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Xiaohua Wang
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yinqing Liang
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
name:Mingjie Zhang
affiliation:
name:Hank Bioengineering Co., Ltd
address:
name:Hank Bioengineering Co., Ltd, Shenzhen, China
type:PostalAddress
type:Organization
type:Person
name:Jibing Chen
url:http://orcid.org/0000-0001-8596-2126
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Lizhi Niu
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
name:Jinan University School
address:
name:Department of Oncology, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Kecheng Xu
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Journal of Cancer Research and Clinical Oncology
issn:
1432-1335
0171-5216
volumeNumber:143
Organization:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
name:Hank Bioengineering Co., Ltd
address:
name:Hank Bioengineering Co., Ltd, Shenzhen, China
type:PostalAddress
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
name:Jinan University School
address:
name:Department of Oncology, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Mao Lin
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
name:Shuzhen Liang
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Xiaohua Wang
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Yinqing Liang
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Mingjie Zhang
affiliation:
name:Hank Bioengineering Co., Ltd
address:
name:Hank Bioengineering Co., Ltd, Shenzhen, China
type:PostalAddress
type:Organization
name:Jibing Chen
url:http://orcid.org/0000-0001-8596-2126
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
email:[email protected]
name:Lizhi Niu
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
name:Jinan University School
address:
name:Department of Oncology, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
email:[email protected]
name:Kecheng Xu
affiliation:
name:Jinan University School
address:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
type:PostalAddress
type:Organization
name:Fuda Cancer Institute
address:
name:Fuda Cancer Institute, Guangzhou, China
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
name:Fuda Cancer Institute, Guangzhou, China
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
name:Hank Bioengineering Co., Ltd, Shenzhen, China
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
name:Fuda Cancer Institute, Guangzhou, China
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
name:Fuda Cancer Institute, Guangzhou, China
name:Department of Oncology, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
name:Department of Biological Treatment Center, Fuda Cancer Hospital, Jinan University School, Guangzhou, China
name:Fuda Cancer Institute, Guangzhou, China
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {đ}(258)
- How much revenue does https://www.springernature.com/gp/authors generate?
- https://link.springernature.com/home/ income
- How much income does https://order.springer.com/public/cart have?
- What's https://submission.nature.com/new-submission/432/3's gross income?
- Financial intake of https://orcid.org/0000-0001-8596-2126
- How much does https://www.springernature.com/gp/librarians/licensing/agc/journals make?
- Find out how much https://doi.org/10.1158/0008-5472.CAN-12-3932 earns monthly
- Find out how much https://doi.org/10.1158%2F0008-5472.CAN-12-3932 earns monthly
- Get to know http://scholar.google.com/scholar_lookup?&title=Tumor-specific%20cytotoxic%20T%20cells%20are%20crucial%20for%20efficacy%20of%20immunomodulatory%20antibodies%20in%20patients%20with%20lung%20cancer&journal=Can%20Res&doi=10.1158%2F0008-5472.CAN-12-3932&volume=73&pages=2381-2388&publication_year=2013&author=Aerts%2CJG&author=Hegmans%2CJP's earnings
- What are the total earnings of https://doi.org/10.1016/j.jaad.2012.02.010?
- How much does https://doi.org/10.1016%2Fj.jaad.2012.02.010 net monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22502948 net monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Grading%20dermatologic%20adverse%20events%20of%20cancer%20treatments%3A%20the%20common%20terminology%20criteria%20for%20adverse%20events%20version%204.0&journal=J%20Am%20Acad%20Dermatol&doi=10.1016%2Fj.jaad.2012.02.010&volume=67&pages=1025-1039&publication_year=2012&author=Chen%2CAP&author=Setser%2CA&author=Anadkat%2CMJ&author=Cotliar%2CJ&author=Olsen%2CEA&author=Garden%2CBC gross monthly?
- How much income is https://doi.org/10.1038/cmi.2013.10 earning monthly?
- How much does https://doi.org/10.1038%2Fcmi.2013.10 rake in every month?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23604045's financial summary
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076738 make?
- How much does http://scholar.google.com/scholar_lookup?&title=NK%20cell-based%20immunotherapy%20for%20malignant%20diseases&journal=Cell%20Mol%20Immunol&doi=10.1038%2Fcmi.2013.10&volume=10&pages=230-252&publication_year=2013&author=Cheng%2CM&author=Chen%2CY&author=Xiao%2CW&author=Sun%2CR&author=Tian%2CZ gross monthly?
- Financial intake of https://doi.org/10.1016/S0065-2776(06)90002-9
- What is the earnings of https://doi.org/10.1016%2FS0065-2776%2806%2990002-9?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16730261's revenue stream
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20immune%20evasion%20by%20tumors&journal=Adv%20Immunol&doi=10.1016%2FS0065-2776%2806%2990002-9&volume=90&pages=51-81&publication_year=2006&author=Drake%2CCG&author=Jaffee%2CE&author=Pardoll%2CDM
- What is the monthly revenue of https://doi.org/10.1016/j.ejca.2008.10.026?
- What's the monthly income of https://doi.org/10.1016%2Fj.ejca.2008.10.026?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19097774 each month?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=New%20response%20evaluation%20criteria%20in%20solid%20tumours%3A%20revised%20RECIST%20guideline%20%28version%201.1%29&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2008.10.026&volume=45&pages=228-247&publication_year=2009&author=Eisenhauer%2CEA&author=Therasse%2CP&author=Bogaerts%2CJ&author=Schwartz%2CLH&author=Sargent%2CD&author=Ford%2CR?
- What's the financial outcome of https://doi.org/10.1097/CCO.0b013e32835ca1b0?
- Earnings of https://doi.org/10.1097%2FCCO.0b013e32835ca1b0
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23262832
- How much does http://scholar.google.com/scholar_lookup?&title=Adjuvant%20treatment%20of%20resected%20nonsmall%20cell%20lung%20cancer%3A%20state%20of%20the%20art%20and%20new%20potential%20developments&journal=Curr%20Opin%20Oncol&doi=10.1097%2FCCO.0b013e32835ca1b0&volume=25&pages=115-120&publication_year=2013&author=Felip%2CE&author=Martinez-Marti%2CA&author=Martinez%2CP&author=Cedres%2CS&author=Navarro%2CA net monthly?
- Explore the financials of https://doi.org/10.1111/j.1399-3089.2009.00510.x
- https://doi.org/10.1111%2Fj.1399-3089.2009.00510.x income
- Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19243557
- Earnings of http://scholar.google.com/scholar_lookup?&title=HLA-Cw4%20expression%20on%20porcine%20endothelial%20cells%20reduces%20cytotoxicity%20and%20adhesion%20mediated%20by%20CD158a%C2%A0%2B%C2%A0human%20NK%20cells&journal=Xenotransplantation&doi=10.1111%2Fj.1399-3089.2009.00510.x&volume=16&pages=19-26&publication_year=2009&author=Forte%2CP&author=Baumann%2CBC&author=Schneider%2CMK&author=Seebach%2CJD
- How much money does https://doi.org/10.1097/01.RVI.0000170858.46668.65 generate?
- How much does https://doi.org/10.1097%2F01.RVI.0000170858.46668.65 make?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Image-guided%20tumor%20ablation%3A%20standardization%20of%20terminology%20and%20reporting%20criteria&journal=J%20Vasc%20Intervent%20Radiol%20JVIR&doi=10.1097%2F01.RVI.0000170858.46668.65&volume=16&pages=765-778&publication_year=2005&author=Goldberg%2CSN&author=Grassi%2CCJ&author=Cardella%2CJF&author=Charboneau%2CJW&author=Dodd%2CGD&author=Dupuy%2CDE?
- How much revenue does https://doi.org/10.1148/radiol.2353042205 produce monthly?
- What's the total monthly financial gain of https://doi.org/10.1148%2Fradiol.2353042205?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15845798's revenue stream
- Find out how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406173 earns monthly
- http://scholar.google.com/scholar_lookup?&title=Image-guided%20tumor%20ablation%3A%20standardization%20of%20terminology%20and%20reporting%20criteria&journal=Radiology&doi=10.1148%2Fradiol.2353042205&volume=235&pages=728-739&publication_year=2005&author=Goldberg%2CSN&author=Grassi%2CCJ&author=Cardella%2CJF&author=Charboneau%2CJW&author=Dodd%2CGD&author=Dupuy%2CDE income
- How much does https://doi.org/10.1016%2FS0192-0561%2898%2900077-0 pull in monthly?
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=10230872
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=The%20immunology%20and%20immunotherapy%20of%20breast%20cancer%3A%20an%20update&journal=Int%20J%20Immunopharmacol&doi=10.1016%2FS0192-0561%2898%2900077-0&volume=21&pages=79-101&publication_year=1999&author=Hadden%2CJW
- What's the income generated by https://doi.org/10.1371/journal.pone.0108958 each month?
- How much money does https://doi.org/10.1371%2Fjournal.pone.0108958 make?
- What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25268709?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182599 make?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Effectiveness%20and%20safety%20of%20chemotherapy%20combined%20with%20dendritic%20cells%20co-cultured%20with%20cytokine-induced%20killer%20cells%20in%20the%20treatment%20of%20advanced%20non-small-cell%20lung%20cancer%3A%20a%20systematic%20review%20and%20meta-analysis&journal=PLoS%20ONE&doi=10.1371%2Fjournal.pone.0108958&volume=9&publication_year=2014&author=Han%2CRX&author=Liu%2CX&author=Pan%2CP&author=Jia%2CYJ&author=Yu%2CJC make?
- How much does https://doi.org/10.1016/j.cell.2011.02.013 rake in every month?
- How much revenue does https://doi.org/10.1016%2Fj.cell.2011.02.013 generate?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21376230 generate?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Hallmarks%20of%20cancer%3A%20the%20next%20generation&journal=Cell&doi=10.1016%2Fj.cell.2011.02.013&volume=144&pages=646-674&publication_year=2011&author=Hanahan%2CD&author=Weinberg%2CRA?
- Monthly income for https://doi.org/10.3892/mco.2014.299
- How much revenue does https://doi.org/10.3892%2Fmco.2014.299 produce monthly?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25054031's revenue stream
- Get to know http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106667's earnings
- Income figures for http://scholar.google.com/scholar_lookup?&title=Prognostic%20value%20of%20peripheral%20and%20local%20forkhead%20box%20P3%2B%20regulatory%20T%20cells%20in%20patients%20with%20non-small-cell%20lung%20cancer&journal=Mol%20Clin%20Oncol&doi=10.3892%2Fmco.2014.299&volume=2&pages=685-694&publication_year=2014&author=Hasegawa%2CT&author=Suzuki%2CH&author=Yamaura%2CT&author=Muto%2CS&author=Okabe%2CN&author=Osugi%2CJ
- What's the revenue for https://doi.org/10.1182/blood-2004-12-4797?
- How much profit is https://doi.org/10.1182%2Fblood-2004-12-4797 making per month?
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15755898?
- How much cash flow does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895123 have monthly?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=Genetic%20modification%20of%20primary%20natural%20killer%20cells%20overcomes%20inhibitory%20signals%20and%20induces%20specific%20killing%20of%20leukemic%20cells&journal=Blood&doi=10.1182%2Fblood-2004-12-4797&volume=106&pages=376-383&publication_year=2005&author=Imai%2CC&author=Iwamoto%2CS&author=Campana%2CD
- Get to know what's the income of https://doi.org/10.1016/j.athoracsur.2003.09.082
- How profitable is https://doi.org/10.1016%2Fj.athoracsur.2003.09.082?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15620967 net monthly?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=The%20acute%20effects%20of%20transthoracic%20cryoablation%20on%20normal%20lung%20evaluated%20in%20a%20porcine%20model&journal=Ann%20Thorac%20Surg&doi=10.1016%2Fj.athoracsur.2003.09.082&volume=79&pages=318-322&publication_year=2005&author=Izumi%2CY&author=Oyama%2CT&author=Ikeda%2CE&author=Kawamura%2CM&author=Kobayashi%2CK?
- Check the income stats for https://doi.org/10.3748/wjg.v20.i9.2267
- How profitable is https://doi.org/10.3748%2Fwjg.v20.i9.2267?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24605026?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942832?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Systematic%20review%20of%20novel%20ablative%20methods%20in%20locally%20advanced%20pancreatic%20cancer&journal=World%20J%20Gastroenterol&doi=10.3748%2Fwjg.v20.i9.2267&volume=20&pages=2267-2278&publication_year=2014&author=Keane%2CMG&author=Bramis%2CK&author=Pereira%2CSP&author=Fusai%2CGK is on a monthly basis
- What's the monthly money flow for https://doi.org/10.1056/NEJM200010263431703?
- What's the revenue for https://doi.org/10.1056%2FNEJM200010263431703?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=11071672
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=A%20randomized%20trial%20of%20postoperative%20adjuvant%20therapy%20in%20patients%20with%20completely%20resected%20stage%20II%20or%20IIIA%20non-small-cell%20lung%20cancer.%20Eastern%20Cooperative%20Oncology%20Group&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJM200010263431703&volume=343&pages=1217-1222&publication_year=2000&author=Keller%2CSM&author=Adak%2CS&author=Wagner%2CH&author=Herskovic%2CA&author=Komaki%2CR&author=Brooks%2CBJ?
- What is the monthly revenue of https://doi.org/10.1245/s10434-015-5034-x?
- How much money does https://doi.org/10.1245%2Fs10434-015-5034-x make?
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26714959 make?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Single-Institution%20experience%20with%20irreversible%20electroporation%20for%20T4%20pancreatic%20cancer%3A%20first%2050%20patients&journal=Ann%20Surg%20Oncol&doi=10.1245%2Fs10434-015-5034-x&volume=23&pages=1736-1743&publication_year=2016&author=Kluger%2CMD&author=Epelboym%2CI&author=Schrope%2CBA&author=Mahendraraj%2CK&author=Hecht%2CEM&author=Susman%2CJ
- Learn about the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=14666732
- How profitable is http://scholar.google.com/scholar_lookup?&title=Combination%20of%20adoptive%20immunotherapy%20with%20Herceptin%20for%20patients%20with%20HER2-expressing%20breast%20cancer&journal=Anticancer%20Res&volume=23&pages=4443-4449&publication_year=2003&author=Kubo%2CM&author=Morisaki%2CT&author=Kuroki%2CH&author=Tasaki%2CA&author=Yamanaka%2CN&author=Matsumoto%2CK?
- What are the earnings of https://doi.org/10.1097/01.tp.0000290681.41859.41?
- What's https://doi.org/10.1097%2F01.tp.0000290681.41859.41's gross income?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18091530
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=KIR%2FHLA%20ligand%20incompatibility%20in%20kidney%20transplantation&journal=Transplantation&doi=10.1097%2F01.tp.0000290681.41859.41&volume=84&pages=1527-1533&publication_year=2007&author=Kunert%2CK&author=Seiler%2CM&author=Mashreghi%2CMF&author=Klippert%2CK&author=Schonemann%2CC&author=Neumann%2CK?
- How much does https://doi.org/10.1097/CJI.0b013e318241d9de make?
- What's the income generated by https://doi.org/10.1097%2FCJI.0b013e318241d9de each month?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22306907
- Find out how much http://scholar.google.com/scholar_lookup?&title=Autologous%20cytokine-induced%20killer%20cell%20transfusion%20in%20combination%20with%20gemcitabine%20plus%20cisplatin%20regimen%20chemotherapy%20for%20metastatic%20nasopharyngeal%20carcinoma&journal=J%20Immunother&doi=10.1097%2FCJI.0b013e318241d9de&volume=35&pages=189-195&publication_year=2012&author=Li%2CJJ&author=Gu%2CMF&author=Pan%2CK&author=Liu%2CLZ&author=Zhang%2CH&author=Shen%2CWX earns monthly
- Explore the financials of https://doi.org/10.1007/s00262-012-1260-2
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22581306 pull in?
- How much does http://scholar.google.com/scholar_lookup?&title=Autologous%20cytokine-induced%20killer%20cell%20immunotherapy%20in%20lung%20cancer%3A%20a%20phase%20II%20clinical%20study&journal=Cancer%20Immunol%20Immunother%20CII&doi=10.1007%2Fs00262-012-1260-2&volume=61&pages=2125-2133&publication_year=2012&author=Li%2CR&author=Wang%2CC&author=Liu%2CL&author=Du%2CC&author=Cao%2CS&author=Yu%2CJ pull in monthly?
- Get to know what's the income of https://doi.org/10.1016/j.imlet.2017.03.004
- What's the financial outcome of https://doi.org/10.1016%2Fj.imlet.2017.03.004?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28274792
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Prospective%20study%20of%20percutaneous%20cryoablation%20combined%20with%20allogenic%20NK%20cell%20immunotherapy%20for%20advanced%20renal%20cell%20cancer&journal=Immunol%20Lett&doi=10.1016%2Fj.imlet.2017.03.004&volume=184&pages=98-104&publication_year=2017&author=Lin%2CM&author=Xu%2CK&author=Liang%2CS&author=Wang%2CX&author=Liang%2CY&author=Zhang%2CM each month?
- https://doi.org/10.1038/nri2073's total income per month
- What is the monthly revenue of https://doi.org/10.1038%2Fnri2073?
- Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17438573
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Prospects%20for%20the%20use%20of%20NK%20cells%20in%20immunotherapy%20of%20human%20cancer&journal=Nat%20Rev%20Immunol&doi=10.1038%2Fnri2073&volume=7&pages=329-339&publication_year=2007&author=Ljunggren%2CHG&author=Malmberg%2CKJ each month?
- What's the revenue for https://doi.org/10.1016/j.canlet.2014.01.004?
- How much revenue does https://doi.org/10.1016%2Fj.canlet.2014.01.004 generate?
- What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24462819's gross income?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Cancer%20statistics%3A%20current%20diagnosis%20and%20treatment%20of%20pancreatic%20cancer%20in%20Shanghai%2C%20China&journal=Cancer%20Lett&doi=10.1016%2Fj.canlet.2014.01.004&volume=346&pages=273-277&publication_year=2014&author=Long%2CJ&author=Luo%2CGP&author=Xiao%2CZW&author=Liu%2CZQ&author=Guo%2CM&author=Liu%2CL produce monthly?
- What's the monthly money flow for https://doi.org/10.1158/1535-7163.MCT-14-0448?
- What's the financial outcome of https://doi.org/10.1158%2F1535-7163.MCT-14-0448?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25349304 generate monthly?
- Monthly income for http://scholar.google.com/scholar_lookup?&title=miR141-CXCL1-CXCR2%20signaling-induced%20Treg%20recruitment%20regulates%20metastases%20and%20survival%20of%20non-small%20cell%20lung%20cancer&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-14-0448&volume=13&pages=3152-3162&publication_year=2014&author=Lv%2CM&author=Xu%2CY&author=Tang%2CR&author=Ren%2CJ&author=Shen%2CS&author=Chen%2CY
- What's https://doi.org/10.1007/s11605-013-2309-z's gross income?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23929188
- How much income does http://scholar.google.com/scholar_lookup?&title=Irreversible%20electroporation%20of%20locally%20advanced%20pancreatic%20head%20adenocarcinoma&journal=J%20Gastrointest%20Surg&doi=10.1007%2Fs11605-013-2309-z&volume=17&pages=1850-1856&publication_year=2013&author=Martin%2CRC have?
- Find out how much https://doi.org/10.3978/j.issn.2078-6891.2015.012 earns monthly
- How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26029461?
- Earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397251
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Irreversible%20electroporation%20of%20locally%20advanced%20pancreatic%20neck%2Fbody%20adenocarcinoma&journal=J%20Gastrointest%20Oncol&doi=10.3978%2Fj.issn.2078-6891.2015.012&volume=6&pages=329-335&publication_year=2015&author=Martin%2CRC produce monthly?
- What is the earnings of https://doi.org/10.1245/s10434-012-2736-1?
- What are the earnings of https://doi.org/10.1245%2Fs10434-012-2736-1?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23128941 make?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Irreversible%20electroporation%20in%20locally%20advanced%20pancreatic%20cancer%3A%20potential%20improved%20overall%20survival&journal=Ann%20Surg%20Oncol&doi=10.1245%2Fs10434-012-2736-1&volume=20&issue=Suppl%203&pages=S443-S449&publication_year=2013&author=Martin%2CRC&author=McFarland%2CK&author=Ellis%2CS&author=Velanovich%2CV?
- What are the earnings of https://doi.org/10.1097/SLA.0000000000001441?
- Get to know what's the income of https://doi.org/10.1097%2FSLA.0000000000001441
- What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26258317?
- How much money does http://scholar.google.com/scholar_lookup?&title=Treatment%20of%20200%20locally%20advanced%20%28stage%20III%29%20pancreatic%20adenocarcinoma%20patients%20with%20irreversible%20electroporation%3A%20safety%20and%20efficacy&journal=Ann%20Surg&doi=10.1097%2FSLA.0000000000001441&volume=262&pages=486-494&publication_year=2015&author=Martin%2CRC&author=Kwon%2CD&author=Chalikonda%2CS&author=Sellers%2CM&author=Kotz%2CE&author=Scoggins%2CC make?
- Learn about the earnings of https://doi.org/10.1002/jso.24404
- What's the monthly income of https://doi.org/10.1002%2Fjso.24404?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27546233?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Irreversible%20electroporation%20in%20locally%20advanced%20pancreatic%20cancer%3A%20a%20call%20for%20standardization%20of%20energy%20delivery&journal=J%20Surg%20Oncol&doi=10.1002%2Fjso.24404&volume=114&pages=865-871&publication_year=2016&author=Martin%2CRC&author=Durham%2CAN&author=Besselink%2CMG&author=Iannitti%2CD&author=Weiss%2CMJ&author=Wolfgang%2CCL is on a monthly basis
- What are the earnings of https://doi.org/10.1002%2F1097-0142%2819810101%2947%3A1%3C207%3A%3AAID-CNCR2820470134%3E3.0.CO%3B2-6?
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=7459811
- Profit of http://scholar.google.com/scholar_lookup?&title=Reporting%20results%20of%20cancer%20treatment&journal=Cancer&doi=10.1002%2F1097-0142%2819810101%2947%3A1%3C207%3A%3AAID-CNCR2820470134%3E3.0.CO%3B2-6&volume=47&pages=207-214&publication_year=1981&author=Miller%2CAB&author=Hoogstraten%2CB&author=Staquet%2CM&author=Winkler%2CA
- Check the income stats for https://doi.org/10.1016/j.coi.2004.07.010
- Financial intake of https://doi.org/10.1016%2Fj.coi.2004.07.010
- Earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15342010
- How much does http://scholar.google.com/scholar_lookup?&title=Killer%20immunoglobulin-like%20receptors&journal=Curr%20Opin%20Immunol&doi=10.1016%2Fj.coi.2004.07.010&volume=16&pages=626-633&publication_year=2004&author=Moretta%2CL&author=Moretta%2CA generate monthly?
- Financial intake of https://doi.org/10.1016/j.jvir.2012.09.012
- https://doi.org/10.1016%2Fj.jvir.2012.09.012's total income per month
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Percutaneous%20irreversible%20electroporation%20for%20downstaging%20and%20control%20of%20unresectable%20pancreatic%20adenocarcinoma&journal=J%20Vasc%20Intervent%20Radiol%20JVIR&doi=10.1016%2Fj.jvir.2012.09.012&volume=23&pages=1613-1621&publication_year=2012&author=Narayanan%2CG&author=Hosein%2CPJ&author=Arora%2CG&author=Barbery%2CKJ&author=Froud%2CT&author=Livingstone%2CAS is on a monthly basis
- Find out how much https://doi.org/10.3978/j.issn.2072-1439.2012.07.13 earns monthly
- How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22934144 bring in?
- See how much http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426750 makes per month
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Cryosurgery%20for%20lung%20cancer&journal=J%20Thorac%20Dis&doi=10.3978%2Fj.issn.2072-1439.2012.07.13&volume=4&pages=408-419&publication_year=2012&author=Niu%2CL&author=Xu%2CK&author=Mu%2CF?
- Get to know what's the income of https://doi.org/10.1097/MPA.0b013e3182965dde
- Find out how much https://doi.org/10.1097%2FMPA.0b013e3182965dde earns monthly
- Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23899940
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Combination%20treatment%20with%20comprehensive%20cryoablation%20and%20immunotherapy%20in%20metastatic%20pancreatic%20cancer&journal=Pancreas&doi=10.1097%2FMPA.0b013e3182965dde&volume=42&pages=1143-1149&publication_year=2013&author=Niu%2CL&author=Chen%2CJ&author=He%2CL&author=Liao%2CM&author=Yuan%2CY&author=Zeng%2CJ?
- What's the income of https://doi.org/10.3748/wjg.v19.i22.3473?
- https://doi.org/10.3748%2Fwjg.v19.i22.3473's revenue stream
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23801841 gross monthly?
- Financial intake of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3683687
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Combination%20treatment%20with%20comprehensive%20cryoablation%20and%20immunotherapy%20in%20metastatic%20hepatocellular%20cancer&journal=World%20J%20Gastroenterol&doi=10.3748%2Fwjg.v19.i22.3473&volume=19&pages=3473-3480&publication_year=2013&author=Niu%2CLZ&author=Li%2CJL&author=Zeng%2CJY&author=Mu%2CF&author=Liao%2CMT&author=Yao%2CF?
- What are the total earnings of https://doi.org/10.1159/000375323?
- How much cash flow does https://doi.org/10.1159%2F000375323 have monthly?
- How much cash flow does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25765775 have monthly?
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Safety%20and%20feasibility%20of%20irreversible%20electroporation%20%28IRE%29%20in%20patients%20with%20locally%20advanced%20pancreatic%20cancer%3A%20results%20of%20a%20prospective%20study&journal=Dig%20Surg&doi=10.1159%2F000375323&volume=32&pages=90-97&publication_year=2015&author=Paiella%2CS&author=Butturini%2CG&author=Frigerio%2CI&author=Salvia%2CR&author=Armatura%2CG&author=Bacchion%2CM bring in?
- How much revenue does https://doi.org/10.1245/s10434-013-3144-x bring in?
- How much does https://doi.org/10.1245%2Fs10434-013-3144-x gross monthly?
- What are the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23892527?
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=The%20efficacy%20of%20cytokine-induced%20killer%20cell%20infusion%20as%20an%20adjuvant%20therapy%20for%20postoperative%20hepatocellular%20carcinoma%20patients&journal=Ann%20Surg%20Oncol&doi=10.1245%2Fs10434-013-3144-x&volume=20&pages=4305-4311&publication_year=2013&author=Pan%2CK&author=Li%2CYQ&author=Wang%2CW&author=Xu%2CL&author=Zhang%2CYJ&author=Zheng%2CHX?
- What's the profit of https://doi.org/10.1158/1078-0432.CCR-14-0082?
- What's the profit of https://doi.org/10.1158%2F1078-0432.CCR-14-0082?
- What's the financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24668644?
- How much does http://scholar.google.com/scholar_lookup?&title=Clinical%20activity%20of%20adjuvant%20cytokine-induced%20killer%20cell%20immunotherapy%20in%20patients%20with%20post-mastectomy%20triple-negative%20breast%20cancer&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-14-0082&volume=20&pages=3003-3011&publication_year=2014&author=Pan%2CK&author=Guan%2CXX&author=Li%2CYQ&author=Zhao%2CJJ&author=Li%2CJJ&author=Qiu%2CHJ gross monthly?
- What is the monthly revenue of https://doi.org/10.1056/NEJMe058110?
- Income figures for https://doi.org/10.1056%2FNEJMe058110
- What's the financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=15972872?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Adjuvant%20chemotherapy%20for%20non-small-cell%20lung%20cancer%E2%80%93the%20smoke%20clears&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMe058110&volume=352&pages=2640-2642&publication_year=2005&author=Pisters%2CKM?
- Earnings of https://doi.org/10.1002/bjs.9716
- What's the profit of https://doi.org/10.1002%2Fbjs.9716?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25524417?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Systematic%20review%20of%20innovative%20ablative%20therapies%20for%20the%20treatment%20of%20locally%20advanced%20pancreatic%20cancer&journal=Br%20J%20Surg&doi=10.1002%2Fbjs.9716&volume=102&pages=182-193&publication_year=2015&author=Rombouts%2CSJ&author=Vogel%2CJA&author=Santvoort%2CHC&author=Lienden%2CKP&author=Hillegersberg%2CR&author=Busch%2COR
- https://doi.org/10.1055/s-0034-1373785's total income per month
- Get to know what's the income of https://doi.org/10.1055%2Fs-0034-1373785
- How much money does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25053862 generate?
- What's the monthly money flow for http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4078112?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=The%20state%20of%20irreversible%20electroporation%20in%20interventional%20oncology&journal=Semin%20Intervent%20Radiol&doi=10.1055%2Fs-0034-1373785&volume=31&pages=111-117&publication_year=2014&author=Silk%2CM&author=Tahour%2CD&author=Srimathveeravalli%2CG&author=Solomon%2CSB&author=Thornton%2CRH
- Check the income stats for https://doi.org/10.1007/s10555-016-9654-9
- Financial intake of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27913998
- Profit of http://scholar.google.com/scholar_lookup?&title=Immunotherapy%20for%20breast%20cancer%3A%20past%2C%20present%2C%20and%20future&journal=Cancer%20Metastasis%20Reviews&doi=10.1007%2Fs10555-016-9654-9&volume=35&pages=525-546&publication_year=2016&author=Spellman%2CA&author=Tang%2CSC
- https://doi.org/10.1016/S1470-2045(12)70126-2's total income per month
- What's the monthly income of https://doi.org/10.1016%2FS1470-2045%2812%2970126-2?
- How much profit is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22748269 making per month?
- How much money does http://scholar.google.com/scholar_lookup?&title=Immunotherapies%20for%20non-small-cell%20lung%20cancer%20and%20mesothelioma&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2812%2970126-2&volume=13&pages=e301-e310&publication_year=2012&author=Thomas%2CA&author=Hassan%2CR generate?
- What's the monthly income of https://doi.org/10.1056/NEJMoa1200690?
- How much money does https://doi.org/10.1056%2FNEJMoa1200690 generate?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22658127 gross monthly?
- How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544539 net monthly?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Safety%2C%20activity%2C%20and%20immune%20correlates%20of%20anti-PD-1%20antibody%20in%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1200690&volume=366&pages=2443-2454&publication_year=2012&author=Topalian%2CSL&author=Hodi%2CFS&author=Brahmer%2CJR&author=Gettinger%2CSN&author=Smith%2CDC&author=McDermott%2CDF?
- Learn how profitable https://doi.org/10.1586/14737140.8.6.993 is on a monthly basis
- Income figures for https://doi.org/10.1586%2F14737140.8.6.993
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18533808 make?
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Novel%20advances%20in%20pancreatic%20cancer%20treatment&journal=Expert%20Rev%20Anticancer%20Ther&doi=10.1586%2F14737140.8.6.993&volume=8&pages=993-1002&publication_year=2008&author=Vulfovich%2CM&author=Rocha-Lima%2CC
- How much does https://doi.org/10.1186/1471-2407-14-251 pull in monthly?
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24720900 make?
- Revenue of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997215
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Clinical%20research%20of%20genetically%20modified%20dendritic%20cells%20in%20combination%20with%20cytokine-induced%20killer%20cell%20treatment%20in%20advanced%20renal%20cancer&journal=BMC%20Cancer&doi=10.1186%2F1471-2407-14-251&volume=14&publication_year=2014&author=Wang%2CD&author=Zhang%2CB&author=Gao%2CH&author=Ding%2CG&author=Wu%2CQ&author=Zhang%2CJ bring in?
- What is the monthly revenue of https://doi.org/10.1111/j.1423-0410.2005.00712.x?
- Get to know https://doi.org/10.1111%2Fj.1423-0410.2005.00712.x's earnings
- What's the total monthly financial gain of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=16359351?
- How much does http://scholar.google.com/scholar_lookup?&title=The%20relevance%20of%20natural%20killer%20cell%20human%20leucocyte%20antigen%20epitopes%20and%20killer%20cell%20immunoglobulin-like%20receptors%20in%20bone%20marrow%20transplantation&journal=Vox%20Sang&doi=10.1111%2Fj.1423-0410.2005.00712.x&volume=90&pages=10-20&publication_year=2006&author=Witt%2CCS&author=Christiansen%2CFT bring in each month?
- How much money does https://doi.org/10.1007/s00262-012-1311-8 make?
- What's the income generated by http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22744010 each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Enhanced%20antitumor%20effects%20of%20DC-activated%20CIKs%20to%20chemotherapy%20treatment%20in%20a%20single%20cohort%20of%20advanced%20non-small-cell%20lung%20cancer%20patients&journal=Cancer%20Immunol%20Immunother%20CII&doi=10.1007%2Fs00262-012-1311-8&volume=62&pages=65-73&publication_year=2013&author=Yang%2CL&author=Ren%2CB&author=Li%2CH&author=Yu%2CJ&author=Cao%2CS&author=Hao%2CX pull in?
- What's the monthly income of https://doi.org/10.1186/1471-2172-11-3?
- Profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20089143
- Profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822749
- Check the income stats for http://scholar.google.com/scholar_lookup?&title=Anti-West%20Nile%20virus%20activity%20of%20in%20vitro%20expanded%20human%20primary%20natural%20killer%20cells&journal=BMC%20Immunol&doi=10.1186%2F1471-2172-11-3&volume=11&publication_year=2010&author=Zhang%2CM&author=Daniel%2CS&author=Huang%2CY&author=Chancey%2CC&author=Huang%2CQ&author=Lei%2CYF
- https://doi.org/10.1097/MPA.0000000000000703's financial summary
- What's the financial intake of https://doi.org/10.1097%2FMPA.0000000000000703?
- What's the monthly income of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28085755?
- How much income is http://scholar.google.com/scholar_lookup?&title=Percutaneous%20irreversible%20electroporation%20for%20ablation%20of%20locally%20advanced%20pancreatic%20cancer%3A%20experience%20from%20a%20Chinese%20Institution&journal=Pancreas&doi=10.1097%2FMPA.0000000000000703&volume=46&pages=e12-e14&publication_year=2017&author=Zhang%2CY&author=Shi%2CJ&author=Zeng%2CJ&author=Alnagger%2CM&author=Zhou%2CL&author=Fang%2CG earning monthly?
- What's the revenue for https://doi.org/10.2147/OTT.S82616?
- Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26124672
- What's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482381?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Enhanced%20NK%20cell%20adoptive%20antitumor%20effects%20against%20breast%20cancer%20in%20vitro%20via%20blockade%20of%20the%20transforming%20growth%20factor-beta%20signaling%20pathway&journal=Onco%20Targets%20Ther&doi=10.2147%2FOTT.S82616&volume=8&pages=1553-1559&publication_year=2015&author=Zhao%2CY&author=Hu%2CJ&author=Li%2CR&author=Song%2CJ&author=Kang%2CY&author=Liu%2CS
- Income figures for https://doi.org/10.1007/s00262-011-1060-0
- How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21681372 pull in monthly?
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Dendritic%20cells%20combining%20with%20cytokine-induced%20killer%20cells%20synergize%20chemotherapy%20in%20patients%20with%20late-stage%20non-small%20cell%20lung%20cancer&journal=Cancer%20Immunol%20Immunother%20CII&doi=10.1007%2Fs00262-011-1060-0&volume=60&pages=1497-1502&publication_year=2011&author=Zhong%2CR&author=Teng%2CJ&author=Han%2CB&author=Zhong%2CH?
- https://doi.org/10.1007/s13277-013-1132-1's financial summary
- What's the profit of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=24006222?
- How much money does http://scholar.google.com/scholar_lookup?&title=A%20prospective%20study%20of%20the%20efficacy%20of%20a%20combination%20of%20autologous%20dendritic%20cells%2C%20cytokine-induced%20killer%20cells%2C%20and%20chemotherapy%20in%20advanced%20non-small%20cell%20lung%20cancer%20patients&journal=Tumour%20Biol&doi=10.1007%2Fs13277-013-1132-1&volume=35&pages=987-994&publication_year=2014&author=Zhong%2CR&author=Han%2CB&author=Zhong%2CH make?
- How much income does https://citation-needed.springer.com/v2/references/10.1007/s00432-017-2513-4?format=refman&flavour=references have?
- Discover the revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mao%20Lin
- How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mao%20Lin%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shuzhen%20Liang pull in monthly?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shuzhen%20Liang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Xiaohua%20Wang generate monthly?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Xiaohua%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What's the financial gain of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yinqing%20Liang?
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yinqing%20Liang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mingjie%20Zhang?
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mingjie%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the income generated by https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jibing%20Chen each month?
- What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jibing%20Chen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lizhi%20Niu?
- Learn how profitable https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lizhi%20Niu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en is on a monthly basis
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kecheng%20Xu's total income per month
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kecheng%20Xu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en income
- Profit of https://s100.copyright.com/AppDispatchServlet?title=Percutaneous%20irreversible%20electroporation%20combined%20with%20allogeneic%20natural%20killer%20cell%20immunotherapy%20for%20patients%20with%20unresectable%20%28stage%20III%2FIV%29%20pancreatic%20cancer%3A%20a%20promising%20treatment&author=Mao%20Lin%20et%20al&contentID=10.1007%2Fs00432-017-2513-4©right=Springer-Verlag%20GmbH%20Germany&publication=0171-5216&publicationDate=2017-09-04&publisherName=SpringerNature&orderBeanReset=true
- What's the total monthly financial gain of https://crossmark.crossref.org/dialog/?doi=10.1007/s00432-017-2513-4?
- Learn how profitable https://citation-needed.springer.com/v2/references/10.1007/s00432-017-2513-4?format=refman&flavour=citation is on a monthly basis
- https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral income
- Learn how profitable https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research is on a monthly basis
- https://www.springernature.com/gp/products's revenue stream
- How much does https://www.springernature.com/gp/librarians pull in?
- Income figures for https://www.springernature.com/gp/societies
- What's the income generated by https://www.springernature.com/gp/partners each month?
- How much does https://www.springer.com/ gross monthly?
- How much profit is https://www.nature.com/ making per month?
- What's the income of https://www.biomedcentral.com/?
- How much does https://www.palgrave.com/ generate monthly?
- https://www.apress.com/ income
- What's the financial gain of https://www.springernature.com/gp/legal/ccpa?
- What's the profit of https://www.springernature.com/gp/info/accessibility?
- What's the income of https://support.springernature.com/en/support/home?
- Monthly income for https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations
- https://www.springernature.com/'s total income per month
Analytics and Tracking {đ}
- Google Tag Manager
Libraries {đ}
- Clipboard.js
- Prism.js
CDN Services {đŠ}
- Crossref